Effects of Varenicline, Depressive Symptoms, and Region of Enrollment on Smoking Cessation in Depressed Smokers

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Nicotine & Tobacco Research

• Publication date

  2019-01-04

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/ntr/nty033PMID 29471329PMCID PMC6329403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms

  2017cited by this paper
• Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications

  2016cited by this paper
• Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.

  2016cited by this paper
• Smoking dependence in 18 European countries: Hard to maintain the hardening hypothesis.

  2015cited by this paper
• Medication Nonadherence, “Professional Subjects,” and Apparent Placebo Responders: Overlapping Challenges for Medications Development

  2015cited by this paper
• The Missing=Smoking Assumption: A Fallacy in Internet-Based Smoking Cessation Trials?

  2015cited by this paper
• Summary of Notifiable Noninfectious Conditions and Disease Outbreaks: Surveillance for Silicosis - Michigan and New Jersey, 2003-2010.

  2015cited by this paper
• Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.

  2015cited by this paper
• Comparisons of three nicotine dependence scales in a multiethnic sample of young adult menthol and non-menthol smokers.

  2015cited by this paper
• Pricing Policies And Control of Tobacco in Europe (PPACTE) project: cross-national comparison of smoking prevalence in 18 European countries

  2014cited by this paper
• Regular Articles: Some General Guidelines for Choosing Missing Data Handling Methods in Educational Research

  2014cited by this paper
• Varenicline and Cytisine Diminish the Dysphoric-Like State Associated with Spontaneous Nicotine Withdrawal in Rats

  2014cited by this paper
• Determinants of use of smoking cessation aids in 27 European countries.

  2014cited by this paper
• The Global Tobacco Epidemic

  2013cited by this paper
• Concealment and fabrication by experienced research subjects

  2013cited by this paper
• Anhedonia and anxiety sensitivity: prospective relationships to nicotine withdrawal symptoms during smoking cessation.

  2013cited by this paper
• Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

  2013cited by this paper
• Vital Signs: Current Cigarette Smoking Among Adults Aged ≥18 Years with Mental Illness — United States, 2009–2011

  2013cited by this paper
• Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.

  2013cited by this paper
• Symptoms of Depression and Smoking Behaviors Following Treatment with Transdermal Nicotine Patch

  2013cited by this paper
• Past major depression and smoking cessation outcome: a systematic review and meta-analysis update.

  2013cited by this paper
• Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression

  2013cited by this paper
• Support for tobacco control interventions: do country of origin and socioeconomic status make a difference?

  2012cited by this paper
• Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005

  2011cited by this paper
• Smoking persistence across countries: a panel data analysis.

  2011cited by this paper
• Vital signs: Current cigarette smoking among adults aged >=18 years --- United States, 2009

  2010cited by this paper
• Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project.

  2010cited by this paper
• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

  2010cited by this paper
• Vital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.

  2010cited by this paper
• Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders.

  2010cited by this paper
• Cigarette smoking among adults and trends in smoking cessation - United States, 2008.

  2009cited by this paper
• Varenicline improves mood and cognition during smoking abstinence.

  2009cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update

  2008cited by this paper
• Dimensions of depressive symptoms and smoking cessation.

  2008cited by this paper
• Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

  2008cited by this paper
• Is the association of smoking and depression a recent phenomenon?

  2006cited by this paper
• US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy.

  2006cited by this paper
• Comparison of the Heavy Smoking Index and of the Fagerstrom Test for Nicotine Dependence in a sample of 749 cigarette smokers.

  2005cited by this paper
• Negative affect and smoking lapses: a prospective analysis.

  2004cited by this paper
• The Health Consequences of Smoking: A Report of the Surgeon General

  2004cited by this paper
• Shape of the relapse curve and long-term abstinence among untreated smokers.

  2004cited by this paper
• Hardening and the hard-core smoker: concepts, evidence, and implications.

  2003cited by this paper
• The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy.

  2003cited by this paper
• Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse?

  2002cited by this paper
• Predicting relapse back to smoking: contrasting affective and physical models of dependence.

  2002cited by this paper
• Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study.

  2000cited by this paper
• Analysis of longitudinal data

  1998cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper

• Baseline predictors of smoking cessation among individuals with current or past major depressive disorder following treatment with varenicline and intensive behavioral treatment.

  2025cites this paper
• Tobacco use disorder in patients with other mental disorders: a dual disorder perspective from clinical neuroscience

  2024cites this paper
• Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial

  2024cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Pathophysiology of nAChRs: limbic circuits and related disorders.

  2023cites this paper
• Nicotine receptor partial agonists for smoking cessation

  2023cites this paper
• Effectiveness of bupropion and varenicline for smokers with baseline depressive symptoms.

  2022cites this paper
• Varenicline (Chantix): The Smoking Cessation Medication Prescribers May Be Avoiding

  2022cites this paper
• Tobacco Use Disorder (TUD) and Dual Disorders: Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society

  2022cites this paper
• Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis

  2022cites this paper
• Depression symptom profiles and long-term response to cognitive behavioral therapy plus contingency management for smoking cessation.

  2021cites this paper
• Psychiatric co-morbidity and multi-morbidity in the EAGLES trial: Descriptive correlates and associations with neuropsychiatric adverse events, treatment adherence, and smoking cessation.

  2021cites this paper
• Medikamente zur Behandlung von Abhängigkeitserkrankungen und abhängigem Verhalten

  2020cites this paper
• Remission from nicotine dependence among people with severe mental illness who received help/services for tobacco/nicotine use

  2020cites this paper
• Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking.

  2019cites this paper
• Additive effectiveness of contingency management on cognitive behavioural treatment for smokers with depression: Six-month abstinence and depression outcomes.

  2019cites this paper